AI assistant
Sending…
BIOGEN INC. — Director's Dealing 2013
May 31, 2013
30291_dirs_2013-05-31_42140026-4fce-4859-9f6e-b5f1e28c1180.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOGEN IDEC INC. (BIIB)
CIK: 0000875045
Period of Report: 2013-05-29
Reporting Person: DENNER ALEXANDER J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-05-29 | Common Stock | M | 3000 | $53.43 | Acquired | 7920 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-05-29 | Stock Option (Right to Buy) | $53.43 | M | 3000 | Disposed | 2019-06-02 | Common Stock (3000) | Direct |
Footnotes
F1: Exercise pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
F2: Granted under one of the Issuer's stock option plans, in an exempt transaction under SEC Rule 16(b)-3(d).
More from BIOGEN INC.
Regulatory Filings
2026
May 14
Major Shareholding Notification
2026
May 6
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Regulatory Filings
2026
Apr 29
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Major Shareholding Notification
2026
Apr 7
Regulatory Filings
2026
Apr 6